Superficial CD34-positive fibroblastic tumor (SCPFT) is a recently described entity that, despite significant pleomorphism, carries a good prognosis. We briefly describe this tumor and its principal differential diagnoses. Recognition of SCPFTs, including the clinical context in which they arise, is important to avoid confusion with other pleomorphic soft tissue tumors, particularly neoplasms in the group of pleomorphic sarcomas, which are typically aggressive tumors that could lead to unnecessary overtreatment.
ArmstrongSMDemiccoEG.What’s new in fibroblastic tumors?Virchows Arch. 2020;476:41-55.
2.
CarterJMWeissSWLinosKDiCaudoDJFolpeAL.Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol. 2014;27:294-302.
3.
LaoIWYuLWangJ.Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology. 2017;70: 394-401.
4.
PulsFPillayNFagmanH, et al. PRDM10-rearranged soft tissue tumor: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2019;43:504-513.
